CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (AMEX: JAV) announced today that it has agreed to sell an aggregate of 7,100,000 shares of its common stock in an underwritten public offering at a price to the public of $6.00 per share. Javelin has granted the underwriters a 30-day option to purchase up to an additional 1,065,000 shares of common stock to cover over-allotments, if any. All of the shares are being offered by Javelin. The offering is expected to close on or about May 16, 2007, subject to customary conditions.
